BioGend Therapeutics Co., Ltd. (TPEX:6733)
26.00
-0.25 (-0.95%)
Sep 8, 2026, 1:30 PM CST
| Market Cap | 3.53B -38.3% |
| Revenue (ttm) | 236.58M +21.3% |
| Net Income | -67.84M |
| EPS | -0.54 |
| Shares Out | 134.32M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 56,986 |
| Open | 25.95 |
| Previous Close | 26.25 |
| Day's Range | 25.70 - 26.20 |
| 52-Week Range | 23.45 - 49.15 |
| Beta | 0.08 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 9, 2026 |